Search
RD06-04
go.drugbank.com/drugs/DB24647InvestigationalRD06-04 is under investigation in clinical trial NCT06986018 (Clinical Study on the Targeted CD19 Universal CAR-T Cell Injection (RD06-04) for the Treatment of IIM and AAV).
Tivanidazole
go.drugbank.com/drugs/DB20215ExperimentalThe usage of the INN stem '-nidazole' in the name indicates that Tivanidazole is a antiprotozoal and radiosensitizer, metronidazole derivative.
BMS-214662
go.drugbank.com/drugs/DB12234Investigationalbeen used in trials studying the treatment of Childhood Myelodysplastic Syndromes, Refractory Anemia With Excess Blasts, Recurrent Adult Acute Myeloid Leukemia, Relapsing Chronic Myelogenous Leukemia, and
Thiodigalactoside
go.drugbank.com/drugs/DB04396ExperimentalThis medication is known to target galectin-1, heat-labile enterotoxin b chain, neurocan core protein, and lactose permease.
Tarcocimab tedromer
go.drugbank.com/drugs/DB18937InvestigationalTarcocimab tedromer is under investigation in clinical trial NCT06270836 (A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Moderately
Synonyms: 240-alanine,241-alanine,243-alanine,449-cysteine], anti-(human vascular endothelial growth factor A) (human-Mus musculus monoclonal OG1950 g1-chain), disulfide with human-Mus musculus monoclonal OG1950 k-chainTiprotimod
go.drugbank.com/drugs/DB20695ExperimentalThe usage of the INN stem '-imod' in the name indicates that Tiprotimod is a immunomodulator, both stimulant/suppressive and stimulant. Tiprotimod has a monoisotopic molecular weight of 275.03 Da.
Fosgonimeton
go.drugbank.com/drugs/DB21516InvestigationalFosgonimeton is under investigation in clinical trial NCT05511558 (A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)).
Vonifimod
go.drugbank.com/drugs/DB21633ExperimentalThe usage of the INN stem '-imod' in the name indicates that Vonifimod is a immunomodulator, both stimulant/suppressive and stimulant. Vonifimod has a monoisotopic molecular weight of 326.27 Da.
Lirodegimod
go.drugbank.com/drugs/DB21675ExperimentalThe usage of the INN stem '-imod' in the name indicates that Lirodegimod is a immunomodulator, both stimulant/suppressive and stimulant. Lirodegimod has a monoisotopic molecular weight of 1256.45 Da.
Ilantimod
go.drugbank.com/drugs/DB21742ExperimentalThe usage of the INN stem '-imod' in the name indicates that Ilantimod is a immunomodulator, both stimulant/suppressive and stimulant. Ilantimod has a monoisotopic molecular weight of 387.11 Da.